Mirae Asset Global Investments’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
2025
Q3
$2.2K Buy
2025
Q2
$1.44K Buy
2025
Q1
$2.33K Buy
2024
Q4
$6.14K Buy